Here are three findings from KPMG’s May 5 survey of 292 executives from healthcare providers, payers and life sciences companies.
1. Forty-five percent of respondents said they expect a drop in profits due to the move to value-based contracts. In 2014, about one-third of respondents said they expected a drop in profits due to the transition.
2. Among respondents who identified as healthcare providers, a slight majority expect their organization’s finances to suffer with the move to value-based contracts — 25 percent expect a modest decline in operating income, 21 percent expect a significant drop and 6 percent expect a steep decline.
3. Respondents said they expect to make several patient care changes with the move to value-based contracts, including introducing more telemedicine options and developing home care programs.
More articles on healthcare finance:
Service cuts, layoffs may not be enough to save Oklahoma hospital, says CFO
CMS finalizes lab fee schedule changes: 5 key takeaways
Why a room full of physicians shouldn’t be asked to keep an $8B secret
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
